Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the <ul>C</ul>hildren with <ul>H</ul>IV <ul>E</ul>arly Anti<ul>r</ul>etroviral Therapy (CHER) Study
<p>Abstract</p> <p>Background</p> <p>Although otorrhea occurs commonly in HIV-infected infants, there are few data. We compared the incidence of otorrhea in infants receiving early vs deferred ART in the Children with HIV Early Antiretroviral (CHER) trial. Infants aged...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/4/448 |